Boston Trust Walden Corp reduced its position in Agilent Technologies, Inc. (NYSE:A – Free Report) by 6.9% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 193,437 shares of the medical research company’s stock after selling 14,444 shares during the period. Boston Trust Walden Corp owned about 0.07% of Agilent Technologies worth $22,048,000 at the end of the most recent reporting period.
Several other institutional investors also recently bought and sold shares of A. SHP Wealth Management acquired a new position in shares of Agilent Technologies during the fourth quarter worth about $26,000. Core Wealth Advisors LLC purchased a new stake in shares of Agilent Technologies during the 4th quarter valued at about $26,000. Board of the Pension Protection Fund purchased a new stake in shares of Agilent Technologies during the 4th quarter valued at about $27,000. Navalign LLC acquired a new position in Agilent Technologies during the 4th quarter worth approximately $27,000. Finally, MV Capital Management Inc. acquired a new position in Agilent Technologies during the 4th quarter worth approximately $28,000.
Wall Street Analyst Weigh In
Several research firms have recently weighed in on A. Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, May 30th. Piper Sandler began coverage on shares of Agilent Technologies in a research report on Thursday, June 11th. They issued a “neutral” rating and a $150.00 target price for the company. Royal Bank Of Canada assumed coverage on shares of Agilent Technologies in a research note on Wednesday, May 27th. They set an “outperform” rating and a $153.00 target price on the stock. Robert W. Baird lifted their price target on Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a research note on Tuesday, May 26th. Finally, Weiss Ratings raised shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 2nd. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $160.88.
Agilent Technologies Stock Up 0.1%
Shares of NYSE A opened at $130.79 on Friday. The business has a fifty day moving average of $124.00 and a two-hundred day moving average of $125.98. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10. The stock has a market cap of $36.94 billion, a PE ratio of 26.26, a PEG ratio of 2.33 and a beta of 1.25. Agilent Technologies, Inc. has a 52-week low of $108.35 and a 52-week high of $160.27.
Agilent Technologies (NYSE:A – Get Free Report) last issued its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, beating analysts’ consensus estimates of $1.41 by $0.08. The business had revenue of $1.83 billion during the quarter, compared to analyst estimates of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. Agilent Technologies’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same quarter last year, the business posted $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, equities research analysts expect that Agilent Technologies, Inc. will post 6 earnings per share for the current fiscal year.
Agilent Technologies Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th will be paid a $0.255 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a yield of 0.8%. Agilent Technologies’s dividend payout ratio (DPR) is currently 20.48%.
Agilent Technologies Company Profile
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
Featured Stories
- Five stocks we like better than Agilent Technologies
- AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus
- Gold and Silver Recovery—3 Precious Metals Stocks for H2 2026
- Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst
- Why Kroger’s Giant Eagle Deal Could Change Everything
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
